Pazolimus: pazopanib plus sirolimus following progression on pazopanib, a retrospective case series analysis. - Katz, D.; Azraq, Y.; Eleyan, F.; Gill, S.; Peretz, T.; Merimsky, O. (BMC Cancer, 2016)